Abstract
Molecular diagnostics has been dependent on genetic or genomic testing or other high-throughput omic technologies and progressed significantly by rapid advances of novel technologies and bioinformatics during the last decade of intensive research. It is now has been moved on to the clinical implication in the diagnosis, individual-level treatment regimens, prognosis, as well as risk assessment and disease prevention [1–3]. In the meanwhile, consumer genomics companies who provide the direct-to-consumer (DTC) testing services are rapidly emerging [4]. Notably, ethical issue, an important topic of debate crossing the fields such as sociology, psychology, and legal issues, is naturally arising and should be carefully considered while the exciting achievement that the field collectively has made [5, 6]. For example, given by the certain features of genetic or genomic information which differentiated it from other medical data, a by-product of genetic testing and secondary or incidental findings of genomic testing are beyond the scope of traditional informed consent. Also, the acquired data for biobank repositories and accompanying databases would make the sensitive information of individual patient to be potentially identifiable. Thus, a comprehensive review of these issues and the establishment of a new protocol or procedure adapted to the current laws and regulations in the field of molecular diagnostics are urgently needed. This chapter will review and discuss the key ethical issues including informed consent and patient privacy during the performance of such testing. We hope these discussions will lead to future standard principles in the course of medical practice.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Shendure J, Findlay GM, Snyder MW. Genomic medicine-progress, pitfalls, and promise. Cell. 2019;177:45–57.
Boycott KM, Hartley T, Biesecker LG, et al. A diagnosis for all rare genetic diseases: the horizon and the next frontiers. Cell. 2019;177:32–7.
Directors ABo. Clinical utility of genetic and genomic services: a position statement of the American College of Medical Genetics and Genomics. Genet Med. 2015;17:505–7.
Allyse MA, Robinson DH, Ferber MJ, et al. Direct-to-consumer testing 2.0: emerging models of direct-to-consumer genetic testing. Mayo Clin Proc. 2018;93:113–20.
Ramos E, Weissman SM. The dawn of consumer-directed testing. Am J Med Genet C Semin Med Genet. 2018;178:89–97.
Directors ABo. Direct-to-consumer genetic testing: a revised position statement of the American College of Medical Genetics and Genomics. Genet Med. 2016;18:207–8.
Appelbaum PS. Clinical practice. Assessment of patients’ competence to consent to treatment. N Engl J Med. 2007;357:1834–40.
Robson ME, Bradbury AR, Arun B, et al. American Society of Clinical Oncology Policy statement update: genetic and genomic testing for cancer susceptibility. J Clin Oncol. 2015;33:3660–7.
Bunnik EM, Schermer MH, Janssens AC. The role of disease characteristics in the ethical debate on personal genome testing. BMC Med Genomics. 2012;5:4.
Korngiebel DM, Zech JM, Chappelle A, et al. Practice implications of expanded genetic testing in oncology. Cancer Invest. 2019;37:39–45.
Marron JM, Joffe S. Ethical considerations in genomic testing for hematologic disorders. Blood. 2017;130:460–5.
Nishimura AA, Shirts BH, Dorschner MO, et al. Development of clinical decision support alerts for pharmacogenomic incidental findings from exome sequencing. Genet Med. 2015;17:939–42.
Dorschner MO, Amendola LM, Turner EH, et al. Actionable, pathogenic incidental findings in 1,000 participants’ exomes. Am J Hum Genet. 2013;93:631–40.
Punj S, Akkari Y, Huang J, et al. Preconception carrier screening by genome sequencing: results from the clinical laboratory. Am J Hum Genet. 2018;102:1078–89.
Manrai AK, Funke BH, Rehm HL, et al. Genetic misdiagnoses and the potential for health disparities. N Engl J Med. 2016;375:655–65.
Ohno-Machado L, Farcas C, Kim J, et al. Genomes in the cloud: balancing privacy rights and the public good. AMIA Jt Summits Transl Sci Proc. 2013;2013:128.
Directors ABo. Points to consider for informed consent for genome/exome sequencing. Genet Med. 2013;15:748–9.
Directors ABo. ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing. Genet Med. 2015;17:68–9.
American Society of Human Genetics Board of Directors, American College of Medical Genetics Board of Directors. Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents. Am J Hum Genet. 1995;57:1233–41.
National Heart Lung, Blood Institute Working Group, Fabsitz RR, et al. Ethical and practical guidelines for reporting genetic research results to study participants: updated guidelines from a National Heart, Lung, and Blood Institute working group. Circ Cardiovasc Genet. 2010;3:574–80.
McGuire AL, Beskow LM. Informed consent in genomics and genetic research. Annu Rev Genomics Hum Genet. 2010;11:361–81.
Molster CM, Bowman FL, Bilkey GA, et al. The evolution of public health genomics: exploring its past, present, and future. Front Public Health. 2018;6:247.
Takashima K, Maru Y, Mori S, et al. Ethical concerns on sharing genomic data including patients’ family members. BMC Med Ethics. 2018;19:61.
Bunnik EM, Janssens AC, Schermer MH. Informed consent in direct-to-consumer personal genome testing: the outline of a model between specific and generic consent. Bioethics. 2014;28:343–51.
Braverman G, Shapiro ZE, Bernstein JA. Ethical issues in contemporary clinical genetics. Mayo Clin Proc Innov Qual Outcomes. 2018;2:81–90.
Dheensa S, Fenwick A, Lucassen A. Approaching confidentiality at a familial level in genomic medicine: a focus group study with healthcare professionals. BMJ Open. 2017;7:e012443.
Prince AE, Roche MI. Genetic information, non-discrimination, and privacy protections in genetic counseling practice. J Genet Couns. 2014;23:891–902.
Taitsman JK, Grimm CM, Agrawal S. Protecting patient privacy and data security. N Engl J Med. 2013;368:977–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 People's Medical Publishing House Co. Ltd.
About this chapter
Cite this chapter
Meng, Q., Qian, X. (2021). Ethics: Informed Consent, Patient Privacy. In: Pan, S., Tang, J. (eds) Clinical Molecular Diagnostics. Springer, Singapore. https://doi.org/10.1007/978-981-16-1037-0_4
Download citation
DOI: https://doi.org/10.1007/978-981-16-1037-0_4
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-16-1036-3
Online ISBN: 978-981-16-1037-0
eBook Packages: MedicineMedicine (R0)